SMART	Ablative Stereotactic MR-guided Adaptive Radiation Therapy
BED	Biologically Effective Dose
BRPC	Borderline Resectable Pancreatic Cancer
bSSFP	Balanced Steady-State Free Precession
CA 19-9	Carbohydrate Antigen 19-9
CT	Computed Tomography
CTCAE	Common Terminology Criteria for Adverse Events
CTV	Clinical Target Volume
DFFS	Distant Failure-Free Survival
DIBH	Deep Inspiration Breath Hold
DVH	Dose–Volume Histogram
ECOG	Eastern Cooperative Oncology Group
ENI	Elective Nodal Irradiation
GTV	Gross Tumor Volume
IMRT	Intensity-Modulated Radiation Therapy
LAPC	Locally Advanced Pancreatic Cancer
LC	Local Control
MRI	Magnetic Resonance Imaging
MRgRT	Magnetic Resonance-guided Radiotherapy
MR-LINAC	Magnetic Resonance Linear Accelerator
OAR	Organ at Risk
OS	Overall Survival
PDAC	Pancreatic Ductal Adenocarcinoma
PET-CT	Positron Emission Tomography–Computed Tomography
PFS	Progression-Free Survival
PTV	Planning Target Volume
PTV_High/PTV\_opt	High-dose Planning Target Volume (Optimized)
PTV_Low	Low-dose Planning Target Volume
RTT	Radiation Therapist
SBRT	Stereotactic Body Radiation Therapy
TFI	Treatment-Free Interval
TRUFI	True Fast Imaging with Steady-State Precession
ULN	Upper Limit of Normal